Patsch W, Patsch J R, Sailer S
Int J Clin Pharmacol Biopharm. 1977 Aug;15(8):394-6.
Twenty-seven diabetic patients, nine treated with insulin, nine treated with tolbutamid, and nine placed on diet, were given either pindolol or placebo 5 mg, three times daily during a 6-week period. The following 6-week period those receiving pindolol in the first 6 weeks received placebo and vice versa. Pindolol had no influence on the concentration of blood glucose, free fatty acids, triglycerides, or total cholesterol. The effect of pindolol on carbohydrate and fat metabolism appears to be of no clinical relevance in diabetic patients receiving their usual therapy.
27名糖尿病患者,其中9名接受胰岛素治疗,9名接受甲苯磺丁脲治疗,9名采用饮食控制,在6周期间每天3次给予他们5毫克吲哚洛尔或安慰剂。在接下来的6周期间,在前6周接受吲哚洛尔治疗的患者改服安慰剂,反之亦然。吲哚洛尔对血糖、游离脂肪酸、甘油三酯或总胆固醇浓度没有影响。对于接受常规治疗的糖尿病患者,吲哚洛尔对碳水化合物和脂肪代谢的影响似乎没有临床意义。